Stay updated on Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.

Latest updates to the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe version history now lists a new revision v3.4.3 and removes the previous v3.4.2 from the log.SummaryDifference0.1%

- Check13 days agoChange DetectedEntries in the Study Status and Contacts/Locations sections were added and removed, updating the trial's status and the list of participating sites.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page shows a new site revision tag v3.4.2, replacing the previous v3.4.1. This appears to be a minor platform update rather than substantive changes to the study record.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0 from the page history.SummaryDifference0.1%

- Check48 days agoChange DetectedNew UI elements were added to the history page, including a glossary toggle and color-coded highlights to indicate additions (green) and deletions (red). Explicit revision labels (e.g., Revision: v3.4.0) are now shown.SummaryDifference0.7%

- Check62 days agoChange DetectedThe page history now includes a new revision entry v3.3.4, and the previous revision v3.3.3 has been removed.SummaryDifference0.1%

Stay in the know with updates to Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.